Agenus Chooses Flex Databases for Enhanced Pharmacovigilance Solutions

Agenus, a global leader in biopharmaceuticals, has selected Flex Databases as its trusted partner for pharmacovigilance (PV) software, bringing cutting-edge technology and exceptional customer support to its clinical safety processes.
With over 26 years in the industry, Craig, a senior leader at Agenus, shared insights on why Flex Databases stood out among other eClinical providers. "Flex Databases went above and beyond to win our business," Craig said. "Unlike larger providers, Flex demonstrated a commitment to meeting our needs, developing customized solutions at no extra cost, and delivering fast, efficient results."
Agenus faced the challenge of improving its adverse event reporting processes while maintaining strict compliance with global regulatory standards. The company found that traditional pharmacovigilance solutions often led to delays and costly contract amendments when dealing with third-party data. With Flex Databases, Agenus now has full control over its pharmacovigilance data, ensuring more timely access and more flexibility in reporting.
One standout example was when Flex Databases worked with Agenus to incorporate modern AI technology to auto-file documents within their Trial Master File (TMF). Despite initial difficulties with integration, Flex developed this capability in-house at no additional cost, showcasing their dedication to supporting Agenus' operational goals.
Agenus was also impressed with Flex's implementation speed. While other providers quoted timelines of over 20 weeks for basic setups, Flex delivered a fully operational CTMS system in just 10 weeks. They even began building Agenus' system environment before contracts were signed, working weekends to meet critical deadlines.
"The level of service and attention to detail from Flex has been exceptional," Craig added. "Their team has made us feel like a top priority, which is rare in this industry. We are confident that we've chosen the right partner for our clinical safety needs."
Agenus also looks forward to using Flex Databases' advanced AI-powered eTMF feature, which promises to provide a more intuitive, faster, and efficient user experience than competing systems.
Conclusion
By choosing Flex Databases, Agenus has gained a powerful, flexible, and user-friendly pharmacovigilance solution that meets its clinical safety and regulatory requirements. With robust reporting capabilities, AI-enhanced features, and outstanding customer support, Flex Databases is proving to be a key partner in Agenus' ongoing commitment to drug safety and regulatory compliance.

Plynární 1617/10, Holešovice, 170 00 Praha 7, Prague, Czech Republic

Flex Databases is a leading provider of innovative eClinical solutions for the pharmaceutical, biotechnology, and CRO industries. Specializing in Clinical Trial Management Systems (CTMS), Trial Master File (TMF), pharmacovigilance, and regulatory reporting, Flex Databases offers user-friendly, scalable solutions designed to streamline clinical trial operations, ensure compliance, and enhance patient safety.
Known for exceptional customer service, Flex Databases provides tailored support, making complex processes simpler and more efficient. With advanced features like AI-powered tools and seamless system integrations, Flex Databases empowers organizations of all sizes to improve trial management and data integrity.
Flex Databases is committed to driving innovation and delivering solutions that meet the evolving needs of the clinical research industry.

Known for exceptional customer service, Flex Databases provides tailored support, making complex processes simpler and more efficient. With advanced features like AI-powered tools and seamless system integrations, Flex Databases empowers organizations of all sizes to improve trial management and data integrity.

Flex Databases is committed to driving innovation and delivering solutions that meet the evolving needs of the clinical research industry.

This release was published on openPR.